Glen Leesman
Impact in
- Pharmaceutical Science top 2%
- Drug Solubulity and Delivery Systems
- Advanced Drug Delivery Systems
-
- Breast Cancer Treatment Studies
- Cancer Genomics and Diagnostics
Papers in
- Oncology 6
- Global Cancer Incidence and Screening 3
-
- Breast Cancer Treatment Studies 6
- Cancer Genomics and Diagnostics 1
- Co-authors
- Patrick J. Sinko (6 shared papers)Gordon L. Amidon (3 shared papers)Daniel A. Norris (1 shared paper)George M. Grass (1 shared paper)Richard L. Elliott (1 shared paper)Steven P. Linke (6 shared papers)Todd Barry (6 shared papers)Pat W. Whitworth (6 shared papers)
- Journals
- Pharmaceutical Research (4 papers)Clinical Cancer Research (2 papers)Cancer Research (2 papers)Journal of Pharmaceutical Sciences (1 paper)Cancers (1 paper)
- Partner nations
- United StatesSwedenSwitzerland
In The Last Decade
Glen Leesman
15 papers receiving 522 citations
Peers
Comparison fields: 5 of 72
- Pharmaceutical Science 198
- Cancer Research 137
- Oncology 197
- Pharmacology 56
- Spectroscopy 86
Countries citing papers authored by Glen Leesman
This map shows the geographic impact of Glen Leesman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Glen Leesman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Glen Leesman more than expected).
Fields of papers citing papers by Glen Leesman
This network shows the impact of papers produced by Glen Leesman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Glen Leesman. The network helps show where Glen Leesman may publish in the future.
Co-authors
The 25 scholars most cited alongside Glen Leesman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1991 | 131 | |
| 2 | 2000 | 80 | |
| 3 | 2018 | 71 | |
| 4 | 1999 | 59 | |
| 5 | 1980 | 56 | |
| 6 | 2020 | 34 | |
| 7 | 1993 | 25 | |
| 8 | 2011 | 24 | |
| 9 | 2011 | 22 | |
| 10 | 2021 | 20 | |
| 11 | 1997 | 10 | |
| 12 | 2018 | 6 | |
| 13 | 1996 | 5 | |
| 14 | 2021 | 4 | |
| 15 | 2017 | 1 |
About Glen Leesman
Glen Leesman is a scholar working on Oncology, Cancer Research, Molecular Biology, Pharmaceutical Science and Spectroscopy, having authored 15 papers that have together received 548 indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (6 papers), Drug Solubulity and Delivery Systems (4 papers), Analytical Chemistry and Chromatography (3 papers), Global Cancer Incidence and Screening (3 papers), Protein purification and stability (2 papers), Antibiotics Pharmacokinetics and Efficacy (2 papers), Breast Lesions and Carcinomas (2 papers) and Cancer Genomics and Diagnostics (1 paper). The work is most often cited by research in Pharmaceutical Science (198 citations), Cancer Research (137 citations), Oncology (197 citations), Pharmacology (56 citations) and Spectroscopy (86 citations). Glen Leesman has collaborated with scholars based in United States, Sweden and Switzerland. Frequent co-authors include Patrick J. Sinko, Gordon L. Amidon, Daniel A. Norris, George M. Grass, Richard L. Elliott, Steven P. Linke, Todd Barry, Pat W. Whitworth, Troy Bremer and Fredrik Wärnberg. Their work appears in journals such as Pharmaceutical Research, Clinical Cancer Research, Cancer Research, Journal of Pharmaceutical Sciences and Cancers.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.